Soluble CD40 ligand in prediction of acute severe pancreatitis

doi:10.3748/wjg.v12.i10.1613

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2676)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

325

HTML

2027

Figures (1-2)

182

Tables (1-2)

142

Sum=2676

Mar 14, 2006 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 14, 2006; 12(10): 1613-1616
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1613

Full Size Figure Download Figure

Figure 2 sCD40L (400, 800, 1 000, 1 200 1 400 and 2 000 pg/L), CRP (50, 150 and 200 mg/L) and Ranson (Ranson score of 2, 3 and 4) ROC curves with selected or historically determined cutoffs in patients with mild and severe pancreatitis.

Citation: Frossard JL, Morel P, Kwak B, Pastor C, Berney T, Buhler L, Von Laufen A, Demulder S, Mach F. Soluble CD40 ligand in prediction of acute severe pancreatitis. World J Gastroenterol 2006; 12(10): 1613-1616
URL: https://www.wjgnet.com/1007-9327/full/v12/i10/1613.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i10.1613